Primary multidrug-resistant Mycobacterium tuberculosis in 2 regions, Eastern Siberia, Russian Federation

Emerging Infectious Diseases

Volumn 19, Issue 10, 2013, Pages 1649-1652

  Zhdanova, Svetlana ^a   Heysell, Scott K ^b   Ogarkov, Oleg ^c   Boyarinova, Galina ^b   Alexeeva, Galina ^d   Pholwat, Suporn ^b   Zorkaltseva, Elena ^c,e   Houpt, Eric R ^b   Savilov, Eugeniy ^a,e  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b UNIVERSITY OF VIRGINIA   (United States)

^c Irkutsk TB Prevention Dispensary   (Russian Federation)

^d Research Practice Center for Phthisiatry   (Russian Federation)

^e Irkutsk State Medical Academy of Continuing Education   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

ADULT; ARTICLE; DNA EXTRACTION; DRUG SENSITIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYLOGENETIC TREE; RUSSIAN FEDERATION;

GENOTYPE; HIV; MDR TB; MIRU-VNTR; MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIAL INTERSPERSED REPETITIVE UNIT; PNCA; PYRAZINAMIDE; RUSSIAN FEDERATION; SIBERIA; TUBERCULOSIS; TUBERCULOSIS AND OTHER MYCOBACTERIA;

ADULT; AMIDOHYDROLASES; AMINO ACID SUBSTITUTION; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CATALASE; CLUSTER ANALYSIS; DNA GYRASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; HUMANS; MINISATELLITE REPEATS; MULTILOCUS SEQUENCE TYPING; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; PENTOSYLTRANSFERASES; PREVALENCE; SIBERIA; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84884257837     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1910.121108     Document Type: Article

References (15)

1. World Health Organization. Global tuberculosis control report. Geneva: The Organization; 2011.
2. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva: The Organization; 2010.
3. Bobkov A, Kazennova E, Khanina T, Bobkova M, Selimova L, Kravchenko A, et al. An HIV type 1 subtype A strain of low genetic diversity continues to spread among injecting drug users in Russia: a study of the new local outbreaks in Moscow and Irkutsk. AIDS Res Hum Retroviruses. 2001;17:257-61. http:// dx.doi.org/10.1089/088922201750063188
4. Central Research Institute of Health Organization and Information. Key indicators of tuberculosis in Russia in 2009 [in Russian] [cited 2012 Apr]. http://tbpolicy.ru/statistic/national/
5. Ogarkov OB, Medvedeva TV, Zozio T, Pogorelov VI, Nekipelov OM, Gutnikova MY, et al. Molecular typing of Mycobacterium tuberculosis strains in Irkutsk (East Siberia) in 2000-2005 [in Russian]. Mol Med. 2007;2:33-8.
6. Mokrousov I, Narvskaya O, Vyazovaya A, Millet J, Otten T, Vishnevsky B, et al. Mycobacterium tuberculosis Beijing genotype in Russia: in search of informative variable-number tandem-repeat loci. J Clin Microbiol. 2008;46:3576-84. http://dx.doi.org/10.1128/ JCM.00414-08
7. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2006;103:2869-73. http://dx.doi.org/10.1073/pnas.0511240103
8. Weniger T, Krawczyk J, Supply P, Niemann S, Harmsen D. MIRU-VNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria. Nucleic Acids Res. 2010;38(Suppl):W326-31. http://dx.doi.org/10.1093/nar/gkq351
9. Demay C, Liens B, Burguière T, Hill V, Couvin D, Millet J, et al. SITVITWEB-a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol. 2012;12:755-66. http://dx.doi.org/10.1016/j.meegid.2012.02.004
10. Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, et al. Molecular detection of mutations associated with first and second-line drug resistance compared with conventional drug susceptibility testing in M. tuberculosis. Antimicrob Agents Chemother. 2011;55:2032-41. http://dx.doi.org/10.1128/ AAC.01550-10
11. Pepperell CS, Granka JM, Alexander DC, Behr MA, Chui L, Gordon J, et al. Dispersal of Mycobacterium tuberculosis via the Canadian fur trade. Proc Natl Acad Sci U S A. 2011;108:6526-31. http://dx.doi.org/10.1073/pnas.1016708108
12. Dymova MA, Kinsht VN, Cherednichenko AG, Khrapov EA, Svistelnik AV, Filipenko ML. Highest prevalence of Mycobacterium Beijing genotype isolates in patients newly diagnosed with tuberculosis in the Novosibirsk oblast, Russian Federation. J Med Microbiol. 2011;60:1003-9. http://dx.doi.org/10.1099/jmm.0.027995-0
13. Heysell SK, Houpt ER. The future of molecular diagnostics for drug-resistant tuberculosis. Expert Rev Mol Diagn. 2012;12:395-405. http://dx.doi.org/10.1586/erm.12.25
14. Hillemann D, Rüsch-Gerdes S, Richter E. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol. 2009;47:1767-72. http://dx.doi.org/10.1128/JCM.00081-09
15. Williams K, Minkowski A, Amoabeng O, Peloquin CA, Taylor D, Andries K, et al. Sterilizing activity of novel combinations lacking first-and second-line drugs in a murine model of tuberculosis. Antimicrob Agents Chemother. 2012;56:3114-20. http://dx.doi. org/10.1128/AAC.00384-12